GE to sell HistoSonics’ soundwave therapy for liver cancer

Jul 19, 2022

ultrasound

GE Healthcare is teaming up with the developer of a non-invasive platform for destroying liver tumors with sound waves.  | Pending FDA approval, HistoSonics will use guided sonic beams to deliver vibrations into the organ without breaking the skin, causing the targeted tissue to break down and liquify.

Source: GE to sell HistoSonics’ soundwave therapy for liver cancer | FierceBiotech

Hire with SEC


Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Pin It on Pinterest